Recommendations for Management of Liver and Biliary Tract Disease in Cystic Fibrosis
- 1 January 1999
- journal article
- guideline
- Published by Wiley in Journal of Pediatric Gastroenterology and Nutrition
- Vol. 28, S1-S13
- https://doi.org/10.1097/00005176-199900001-00001
Abstract
No abstract availableThis publication has 69 references indexed in Scilit:
- Ursodeoxycholic acid improves the hepatic metabolism of essential fatty acids and retinol in children with cystic fibrosisThe Journal of Pediatrics, 1997
- Clinical denouement and mutation analysis of patients with cystic fibrosis undergoing liver transplantation for biliary cirrhosisThe Journal of Pediatrics, 1995
- Analysis of risk factors for the development of liver disease associated with cystic fibrosisThe Journal of Pediatrics, 1994
- Liver function and morphology during long‐term fatty acid supplementation in cystic fibrosisLiver International, 1994
- Effects of ursodeoxycholic acid on liver function in patients with cystic fibrosis and chronic cholestasisThe Journal of Pediatrics, 1992
- Genotype Analysis for ΔF508, G551d and R553x Mutations in Children and Young Adults With Cystic Fibrosis With and Without Chronic Liver DiseaseHepatology, 1992
- Liver Disease and Common-Bile-Duct Stenosis in Cystic FibrosisNew England Journal of Medicine, 1988
- Propranolol therapy for portal hypertension in childrenThe Journal of Pediatrics, 1985
- Hepatic changes in young infants with cystic fibrosis: Possible relation to focal biliary cirrhosisThe Journal of Pediatrics, 1975
- Cystic fibrosis with extensive fat replacement of the liverThe Journal of Pediatrics, 1966